Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ44606 Inhibitors

FLJ44606 inhibitors represent a class of chemical compounds that specifically target the FLJ44606 protein or its associated signaling pathways. FLJ44606, also known as DDX6, is an RNA helicase that plays a critical role in RNA metabolism, including processes like RNA decay, translational repression, and the formation of cytoplasmic processing bodies (P-bodies). These inhibitors function by interacting with the protein's key domains, such as the helicase or ATP-binding domains, disrupting its ability to unwind RNA or mediate RNA-protein interactions. This disruption affects various cellular functions, especially those associated with post-transcriptional gene regulation and RNA stability, leading to alterations in protein synthesis and gene expression patterns.

The mechanisms of FLJ44606 inhibitors are often highly specific, binding to essential active sites within the protein or preventing its interaction with other cellular machinery involved in RNA processing. The inhibition of FLJ44606 can lead to profound effects on cellular pathways dependent on efficient RNA turnover and translational regulation, affecting key processes such as cell growth, differentiation, and stress responses. Additionally, these inhibitors may interfere with the formation or function of P-bodies, which are crucial for RNA storage and degradation. As a result, FLJ44606 inhibitors are valuable tools in molecular biology for studying the role of DDX6 and related RNA helicases in cellular homeostasis and gene regulation.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

An Aurora kinase inhibitor that might affect FLJ44606 activity if it is involved in the regulation of the cell cycle and mitosis.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

A SERCA pump inhibitor that disrupts calcium homeostasis, potentially affecting FLJ44606 if it is regulated by intracellular calcium levels.